Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
535 | 14838 | 49.8 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
497 | 3 | CANNABINOID//ANANDAMIDE//ENDOCANNABINOIDS | 22707 |
535 | 2 | CANNABINOID//ENDOCANNABINOIDS//ANANDAMIDE | 14838 |
241 | 1 | CANNABINOID//CANNABINOID RECEPTORS//CB2 RECEPTOR | 3838 |
651 | 1 | CANNABINOID//CB1 RECEPTOR//ENDOCANNABINOIDS | 3208 |
2851 | 1 | ANANDAMIDE//FATTY ACID AMIDE HYDROLASE//N ACYLETHANOLAMINE | 2131 |
6717 | 1 | CANNABIS//MARIJUANA//CANNABIDIOL | 1452 |
8413 | 1 | RIMONABANT//ENDOCANNABINOIDS//TARANABANT | 1255 |
9204 | 1 | MEDICAL MARIJUANA//CANNABIS//SATIVEX | 1178 |
16937 | 1 | CANNABIS SATIVA//CANNABIS SATIVA L//HEMP | 626 |
17994 | 1 | SEZ F BOTTAZZI//SEZ BOTTAZZI//DIPARTIMENTO STUDI | 571 |
22065 | 1 | MICROSOMAL ALDEHYDE OXYGENASE//XENOBIOT METAB ENVIRONM TOXICOL//7 HYDROXY DELTA8 TETRAHYDROCANNABINOL | 395 |
29527 | 1 | 2 ARACHIDONOYLGLYCEROL ANANDAMIDE//ANANDAMIDE TRANSPORT INHIBITORS//ANTIGLAUCOMA ACTIVITY | 184 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CANNABINOID | authKW | 4057901 | 18% | 75% | 2631 |
2 | ENDOCANNABINOIDS | authKW | 2117403 | 9% | 77% | 1335 |
3 | ANANDAMIDE | authKW | 1995892 | 8% | 83% | 1163 |
4 | CANNABINOID RECEPTORS | authKW | 1476709 | 6% | 82% | 871 |
5 | CB1 RECEPTOR | authKW | 910758 | 4% | 82% | 542 |
6 | CANNABIS | authKW | 858996 | 7% | 38% | 1089 |
7 | MARIJUANA | authKW | 753711 | 5% | 45% | 811 |
8 | 2 ARACHIDONOYLGLYCEROL | authKW | 663654 | 2% | 90% | 358 |
9 | CANNABIDIOL | authKW | 626135 | 2% | 83% | 369 |
10 | FATTY ACID AMIDE HYDROLASE | authKW | 606192 | 2% | 91% | 324 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 43893 | 33% | 1% | 4869 |
2 | Neurosciences | 35269 | 30% | 0% | 4393 |
3 | Substance Abuse | 23433 | 6% | 1% | 898 |
4 | Psychiatry | 11602 | 11% | 0% | 1633 |
5 | Chemistry, Medicinal | 6039 | 7% | 0% | 991 |
6 | Behavioral Sciences | 3860 | 4% | 0% | 605 |
7 | Clinical Neurology | 1444 | 6% | 0% | 872 |
8 | Biochemistry & Molecular Biology | 1370 | 13% | 0% | 1877 |
9 | Endocrinology & Metabolism | 1040 | 5% | 0% | 669 |
10 | Psychology, Clinical | 761 | 2% | 0% | 308 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ENDOCANNABINOID GRP | 565737 | 2% | 75% | 365 |
2 | GILL BIOMOL SCI | 90804 | 0% | 71% | 62 |
3 | EUROPEAN BRAIN CERC | 73808 | 0% | 58% | 62 |
4 | PHYSIOL STUDIES | 70009 | 1% | 34% | 101 |
5 | UNITE CHIM PHARMACEUT RADIOPHARM | 67654 | 0% | 65% | 51 |
6 | BIOMOL CHEM | 59480 | 2% | 12% | 253 |
7 | PHARMACOL CLIN NEUROSCI | 47465 | 1% | 22% | 106 |
8 | OYO INVEST | 44071 | 0% | 79% | 27 |
9 | CANNABIS PREVENT INFORMAT | 41197 | 0% | 53% | 38 |
10 | PRECLIN PHARMACOL SECT | 35701 | 0% | 30% | 59 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BRITISH JOURNAL OF PHARMACOLOGY | 24315 | 3% | 3% | 464 |
2 | PSYCHOPHARMACOLOGY | 15878 | 2% | 3% | 310 |
3 | NEUROPHARMACOLOGY | 13985 | 2% | 3% | 256 |
4 | BEHAVIOURAL PHARMACOLOGY | 13341 | 1% | 6% | 113 |
5 | DRUG AND ALCOHOL DEPENDENCE | 12416 | 1% | 3% | 193 |
6 | PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR | 12269 | 2% | 2% | 277 |
7 | NEUROPSYCHOPHARMACOLOGY | 10760 | 1% | 3% | 165 |
8 | EUROPEAN JOURNAL OF PHARMACOLOGY | 10582 | 3% | 1% | 391 |
9 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 8591 | 2% | 1% | 305 |
10 | JOURNAL OF PSYCHOPHARMACOLOGY | 5896 | 1% | 4% | 82 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CANNABINOID | 4057901 | 18% | 75% | 2631 | Search CANNABINOID | Search CANNABINOID |
2 | ENDOCANNABINOIDS | 2117403 | 9% | 77% | 1335 | Search ENDOCANNABINOIDS | Search ENDOCANNABINOIDS |
3 | ANANDAMIDE | 1995892 | 8% | 83% | 1163 | Search ANANDAMIDE | Search ANANDAMIDE |
4 | CANNABINOID RECEPTORS | 1476709 | 6% | 82% | 871 | Search CANNABINOID+RECEPTORS | Search CANNABINOID+RECEPTORS |
5 | CB1 RECEPTOR | 910758 | 4% | 82% | 542 | Search CB1+RECEPTOR | Search CB1+RECEPTOR |
6 | CANNABIS | 858996 | 7% | 38% | 1089 | Search CANNABIS | Search CANNABIS |
7 | MARIJUANA | 753711 | 5% | 45% | 811 | Search MARIJUANA | Search MARIJUANA |
8 | 2 ARACHIDONOYLGLYCEROL | 663654 | 2% | 90% | 358 | Search 2+ARACHIDONOYLGLYCEROL | Search 2+ARACHIDONOYLGLYCEROL |
9 | CANNABIDIOL | 626135 | 2% | 83% | 369 | Search CANNABIDIOL | Search CANNABIDIOL |
10 | FATTY ACID AMIDE HYDROLASE | 606192 | 2% | 91% | 324 | Search FATTY+ACID+AMIDE+HYDROLASE | Search FATTY+ACID+AMIDE+HYDROLASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PACHER, P , BATKAI, S , KUNOS, G , (2006) THE ENDOCANNABINOID SYSTEM AS AN EMERGING TARGET OF PHARMACOTHERAPY.PHARMACOLOGICAL REVIEWS. VOL. 58. ISSUE 3. P. 389-462 | 946 | 84% | 790 |
2 | LIGRESTI, A , DE PETROCELLIS, L , DI MARZO, V , (2016) FROM PHYTOCANNABINOIDS TO CANNABINOID RECEPTORS AND ENDOCANNABINOIDS: PLEIOTROPIC PHYSIOLOGICAL AND PATHOLOGICAL ROLES THROUGH COMPLEX PHARMACOLOGY.PHYSIOLOGICAL REVIEWS. VOL. 96. ISSUE 4. P. 1593 -1659 | 788 | 88% | 1 |
3 | HOWLETT, AC , BARTH, F , BONNER, TI , CABRAL, G , CASELLAS, P , DEVANE, WA , FELDER, CC , HERKENHAM, M , MACKIE, K , MARTIN, BR , ET AL (2002) INTERNATIONAL UNION OF PHARMACOLOGY. XXVII. CLASSIFICATION OF CANNABINOID RECEPTORS.PHARMACOLOGICAL REVIEWS. VOL. 54. ISSUE 2. P. 161 -202 | 369 | 93% | 1398 |
4 | HASHIMOTODANI, Y , UCHIGASHIMA, M , WATANABE, M , KANO, M , OHNO-SHOSAKU, T , (2009) ENDOCANNABINOID-MEDIATED CONTROL OF SYNAPTIC TRANSMISSION.PHYSIOLOGICAL REVIEWS. VOL. 89. ISSUE 1. P. 309 -380 | 418 | 73% | 502 |
5 | LAMBERT, DM , FOWLER, CJ , (2005) THE ENDOCANNABINOID SYSTEM: DRUG TARGETS, LEAD COMPOUNDS, AND POTENTIAL THERAPEUTIC APPLICATIONS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 48. ISSUE 16. P. 5059-5087 | 376 | 96% | 222 |
6 | IANNOTTI, FA , DI MARZO, V , PETROSINO, S , (2016) ENDOCANNABINOIDS AND ENDOCANNABINOID-RELATED MEDIATORS: TARGETS, METABOLISM AND ROLE IN NEUROLOGICAL DISORDERS.PROGRESS IN LIPID RESEARCH. VOL. 62. ISSUE . P. 107 -128 | 289 | 81% | 6 |
7 | BARON, EP , (2015) COMPREHENSIVE REVIEW OF MEDICINAL MARIJUANA, CANNABINOIDS, AND THERAPEUTIC IMPLICATIONS IN MEDICINE AND HEADACHE: WHAT A LONG STRANGE TRIP IT'S BEEN ....HEADACHE. VOL. 55. ISSUE 6. P. 885 -916 | 394 | 74% | 8 |
8 | PACHER, P , KUNOS, G , (2013) MODULATING THE ENDOCANNABINOID SYSTEM IN HUMAN HEALTH AND DISEASE SUCCESSES AND FAILURES.FEBS JOURNAL. VOL. 280. ISSUE 9. P. 1918 -1943 | 239 | 92% | 104 |
9 | FREUND, TF , KATONA, I , PIOMELLI, D , (2003) ROLE OF ENDOGENOUS CANNABINOIDS IN SYNAPTIC SIGNALING.PHYSIOLOGICAL REVIEWS. VOL. 83. ISSUE 3. P. 1017-1066 | 282 | 79% | 839 |
10 | SERRANO, A , PARSONS, LH , (2011) ENDOCANNABINOID INFLUENCE IN DRUG REINFORCEMENT, DEPENDENCE AND ADDICTION-RELATED BEHAVIORS.PHARMACOLOGY & THERAPEUTICS. VOL. 132. ISSUE 3. P. 215-241 | 386 | 74% | 44 |
Classes with closest relation at Level 2 |